Transcatheter aortic valve replacement (TAVR) is a rapidly expanding alternative to
surgical aortic valve replacement for patients deemed inoperable or at high or
intermediate operative risk. Yet, residual aortic regurgitation (AR) secondary to
paravalvular leaks (PVL) remains a procedural limitation.[1] Although residual AR after TAVR is frequent, affecting
up to approximately 70% of the treated patients,[2]-[4] it
is moderate to severe in approximately 12% of these[4] and steadily below 5% with current-generation devices, which
come with specific sealing features.[1]
Noteworthy, moderate/severe AR has a detrimental clinical impact after TAVR, with a
3-fold increase in 30-day mortality and a 2.3-fold increase in 1-year
mortality.[4] Thus, its accurate
assessment and quantification with a multimodality approach is key for appropriate
utilization of additional procedures to reduce PVL, such as balloon post-dilatation
(BPD), valve-in-valve, or leak closure.[1],[5]While Doppler echocardiography has been the most common method to assess AR following
TAVR, its accurate quantification is challenging since AR jets are often multiple and
eccentric.[3],[5]-[7]
Therefore, other methods for proper AR assessment have been evaluated in recent years,
such as 3D echocardiography, hemodynamic AR index, aortography and even cardiovascular
magnetic resonance, each one with its specific advantages and disadvantages.[1],[5],[7]In the current issue of the journal, Miyazaki et al.[8] investigate a quantitative angiographic assessment of AR by
videodensitometry (VD-AR) before and after BPD was performed. VD-AR was shown to
decrease significantly from 24.0 [18.0-30.5] % to 12.0 [5.5-19.0] % (p < 0.001) after
BPD, with some degree of AR grade improvement for up to 70% of patients treated. Of
note, significant AR (VD-AR > 17%) was observed in 47 patients (77%) before and in 19
patients (31%) after BPD; moreover, in up to a quarter of these, pre-BPD VD-AR was below
17%, indicating that this additional maneuver could have been avoided. The study has its
inherent limitations, e.g., the cohort was relatively small, with retrospective patient
selection and imaging acquisition, and the decision whether or not to perform BPD was
left to the discretion of the operators. Accordingly, the study only comprises cases
where BPD was deemed necessary, and only aortograms with good quality imaging were
selected.Notably, the technique used to quantify VD-AR is a novel method that can accurately
determine the regurgitation fraction in aortograms performed during TAVR; it uses
dedicated software and showed excellent reproducibility and accuracy.[9],[10] This technique provides an accurate assessment of the
severity of PVL, and a VD-AR index greater than 17% correlated with increased mortality
and with impaired cardiac reverse remodeling after TAVR.[11],[12] And while VD-AR measurements are performed offline only,
real-time online assessment is underway so as to enable this method to help guiding TAVR
in the near future. After all, BPD is currently performed in about 10% to 20% of
patients following TAVR, and it reduces the severity of PVL by at least one grade in
more than two thirds of patients.[13],[14]
Nevertheless, BPD may be associated with an increased risk of cerebrovascular events and
annular trauma, therefore judicious utilization of this procedure is
recommended.[13],[14]In conclusion, since PVL has a negative impact on clinical outcomes after TAVR, its
proper assessment through a multimodality, multiparametric, integrative approach is
fundamental. Priority should be given to PVL prevention through accurate sizing of
aortic annulus by 3D imaging techniques, THV devices with improved sealing features, and
optimal THV sizing and positioning. Still, if PVL does occur after TAVR, the
interventional cardiologist can consider corrective procedures such as BPD,
valve-in-valve, or leak closure. The novel VD-AR after TAVR also allows quantitatively
assessing post-TAVR regurgitation and may assist decision making on whether or not to
perform BPD, as well as determining its efficacy. Future prospective studies are
warranted to further confirm the present results.
Authors: L Nombela-Franco; H Barbosa Ribeiro; R Allende; M Urena; D Doyle; E Dumont; R Delarochellière; J Rodés-Cabau Journal: Minerva Cardioangiol Date: 2013-10 Impact factor: 1.347
Authors: Mohammad Abdelghani; Hiroki Tateishi; Yosuke Miyazaki; Rafael Cavalcante; Osama I I Soliman; Jan G Tijssen; Robbert J de Winter; Jan Baan; Yoshinobu Onuma; Carlos M Campos; Rogério S Leite; José A Mangione; Alexandre Abizaid; Pedro A Lemos; Fabio S de Brito; Patrick W Serruys Journal: Catheter Cardiovasc Interv Date: 2017-01-21 Impact factor: 2.692
Authors: Ganesh Athappan; Eshan Patvardhan; E Murat Tuzcu; Lars Georg Svensson; Pedro A Lemos; Chiara Fraccaro; Giuseppe Tarantini; Jan-Malte Sinning; Georg Nickenig; Davide Capodanno; Corrado Tamburino; Azeem Latib; Antonio Colombo; Samir R Kapadia Journal: J Am Coll Cardiol Date: 2013-04-16 Impact factor: 24.094
Authors: Luis Nombela-Franco; Josep Rodés-Cabau; Robert DeLarochellière; Eric Larose; Daniel Doyle; Jacques Villeneuve; Sébastien Bergeron; Mathieu Bernier; Ignacio J Amat-Santos; Michael Mok; Marina Urena; Michel Rheault; Jean Dumesnil; Mélanie Côté; Philippe Pibarot; Eric Dumont Journal: JACC Cardiovasc Interv Date: 2012-05 Impact factor: 11.195
Authors: Mohamed Abdel-Wahab; Mohammad Abdelghani; Yosuke Miyazaki; Erik W Holy; Constanze Merten; Dirk Zachow; Pim Tonino; Marcel C M Rutten; Frans N van de Vosse; Marie-Angele Morel; Yoshinobu Onuma; Patrick W Serruys; Gert Richardt; Osama I Soliman Journal: JACC Cardiovasc Interv Date: 2018-01-17 Impact factor: 11.195
Authors: Rebecca T Hahn; Philippe Pibarot; William J Stewart; Neil J Weissman; Deepika Gopalakrishnan; Martin G Keane; Saif Anwaruddin; Zuyue Wang; Martin Bilsker; Brian R Lindman; Howard C Herrmann; Susheel K Kodali; Raj Makkar; Vinod H Thourani; Lars G Svensson; Jodi J Akin; William N Anderson; Martin B Leon; Pamela S Douglas Journal: J Am Coll Cardiol Date: 2013-04-23 Impact factor: 24.094
Authors: Hiroki Tateishi; Carlos M Campos; Mohammad Abdelghani; Rogério S Leite; José A Mangione; Lizet Bary; Osama I I Soliman; Ernest Spitzer; Marco A Perin; Yoshinobu Onuma; Patrick W Serruys; Pedro A Lemos; Fabio S Brito Journal: EuroIntervention Date: 2016-03 Impact factor: 6.534
Authors: Mohammad Abdelghani; Yosuke Miyazaki; Ellen S de Boer; Jean-Paul Aben; Math van Sloun; Todd Suchecki; Marcel van 't Veer; Osama Soliman; Yoshinobu Onuma; Robbert de Winter; Pim A L Tonino; Frans N van de Vosse; Marcel C M Rutten; Patrick W Serruys Journal: EuroIntervention Date: 2018-01-20 Impact factor: 6.534